UTransforma

Keyphrases

1. Colombia 100%
2. Aedes Mosquito 87%
3. Social Construction of Risk 87%
4. Lay People 87%
5. Prevention Practices 87%
6. Risk Practices 87%
7. Mosquito-borne Diseases 87%
8. Risk Discourse 58%
9. Community Leaders 58%
10. Pregnant Women 43%
11. Functional Potential 43%
12. Critical Limb Ischemia 43%
13. Functional Mechanism 43%
14. Collaborative Governance 43%
15. Organizational Action 43%
16. Governance Systems 43%
17. Music Education 43%
18. Augmented Reality 43%
19. Social Appropriation 43%
20. Innovation Development 43%
21. Research Innovation 43%
22. Training Aids 43%
23. Technical Assistance 43%
24. Scientific Dissemination 43%
25. Technology Entrepreneurship 43%
26. Obesity 43%
27. Preadolescent children 43%
28. Viable System Model 43%
29. Entrepreneurship 43%
30. Population-representative Study 43%
31. Mesenchymal Stem Cells 43%
32. Diabetes Prevalence 43%
33. Pooled Analysis 43%
34. Therapeutic Potential 43%
35. Operative 43%
36. Global Variation 43%
37. Developing Countries 43%
38. Hemoglobin A1c (HbA1c) 43%
39. World Trends 43%
40. Diabetes Diagnosis 43%
41. Fasting Plasma Glucose 43%
42. Prevalence-based 43%
43. Trajectory Optimization 43%
44. Neural Network 43%
45. Automatic Manipulator 43%
46. Women's Perceptions 43%
47. Generic Competencies 43%
48. Linear Regression Model 43%
49. Signal Amplification by Reversible Exchange (SABRE) 43%
50. Zika Virus 43%
51. Limb Amputation 29%
52. Health Officials 29%
53. Lay Community 29%
54. Ethnographic Study 29%
55. Government Officials 29%
56. Open-ended Interviews 29%
57. Medical Sociology 29%
58. Sociocultural Context 29%
59. Dengue 29%
60. Chikungunya Virus (CHIKV) 29%
61. Disease Prevention 29%
62. Article Analysis 29%
63. Disease Control 29%
64. Medical Anthropology 29%
65. Zika 29%
66. Vector-borne Disease 29%
67. Public Health 29%
68. Diabetes 27%
69. Posterior Probability 21%
70. Viral Outbreaks 21%
71. School-age children 18%
72. School Adolescents 18%
73. Teaching Materials 17%
74. Free Hemoglobin 16%
75. Surgery Therapy 14%
76. Immunomodulation 14%
77. Quality of Life 14%
78. New Blood Vessel 14%
79. Mechanism of Action 14%
80. Amputation Rate 14%
81. Refractory Disease 14%
82. Severe Manifestations 14%
83. Pain at Rest 14%
84. Chronic Limb-threatening Ischemia 14%
85. Regenerative Properties 14%
86. Therapeutic Agents 14%
87. Open Vascular Surgery 14%
88. Lower Limb Arteries 14%
89. High Morbidity 14%
90. Endovascular Therapy 14%
91. Atherosclerotic Occlusive Disease 14%
92. High Amputations 14%
93. Severe Pain 14%
94. Revascularization 14%
95. Semidefinite Programming 14%
96. Living Conditions 14%
97. Tissue Regeneration 14%
98. Peripheral Arterial Disease 14%
99. Cell-based 14%
100. Regenerative Medicine 14%